| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Grail has tapped testing giant Quest Diagnostics to help roll out its upcoming multi-cancer blood test, expected to launch in the coming months.
Low-cost rapid COVID-19 testing is now more accessible across the city, thanks to a new testing program being rolled out by the state. It's part of Gov. Cuomo’s New York Forward Rapid Test Program. It will take place at select CVS, Quest Diagnostics and Clarity MedHealth mobile labs across New York City.
Quest Diagnostics officials announced this week that its turnaround times for COVID-19 testing are faster than at any other time during the pandemic — with the “vast majority” being turned around in one day.
Quest Diagnostics said Tuesday it is now sequencing 2,000 tests a week, doubling the amount of genomic sequencing it started performing last month. The company said it is sequencing the tests for the US Centers for Disease Control and Prevention.
Steve Rusckowski, Quest Diagnostics CEO, joins ‘Closing Bell’ to discuss coronavirus testing, covid variants, and his outlook on the pandemic as coronavirus cases decrease in the U.S.